These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3763446)

  • 1. [Immunotherapy with Corynebacterium parvum in experimental influenza virus infections and mixed infections in mice].
    Denys A; Kowalska M; Szydłowska T; Białek J
    Pol Tyg Lek; 1986 May; 41(19):619-23. PubMed ID: 3763446
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of cancer with corynebacterium parvum.
    Halpern B
    Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of the effects of BCG and Corynebacterium parvum vaccines in experimental infection of mice with influenza virus. Foot pad test, splenic indicator and histologic changes in the thymus gland, spleen and lymph nodes].
    Ciebiada I; Błoch P; Kulig A; Denys A
    Med Dosw Mikrobiol; 1989; 41(2):92-9. PubMed ID: 2586194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Corynebacterium parvum in influenza infected mice.
    Białek J; Denys A; Kowalska M; Ciebiada I; Szydłowska T
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):421-30. PubMed ID: 2639639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum.
    Tan SG; Cotterill JA; Roberts MM; Cunliffe WJ
    Acta Derm Venereol; 1978; 58(6):551-3. PubMed ID: 83086
    [No Abstract]   [Full Text] [Related]  

  • 9. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
    Karrer K; Rella W; Goldin A
    Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
    [No Abstract]   [Full Text] [Related]  

  • 10. Macrophage activation and increased resistance to infection in immunosuppressed mice treated with Corynebacterium parvum vaccine or pyran copolymer.
    Stinnett JD; Morris MJ; Alexander JW
    J Reticuloendothel Soc; 1979 May; 25(5):525-31. PubMed ID: 458782
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced resistance of Corynebacterium parvum-treated mice to infection by bacteria.
    Adlam C; Broughton ES; Scott MT
    J Med Microbiol; 1972 Feb; 5(1):Pvii. PubMed ID: 4336739
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects on the lymphreticular system and inhibition of liver microsomaal cytochrome P-450 in mice administered Priopionibacterium acnes (Corynebacterium parvum) bacterin].
    Ocenásková J; Mára M; Bednár M; Veselská M; Adamcová D
    Cesk Epidemiol Mikrobiol Imunol; 1985 Mar; 34(2):100-6. PubMed ID: 3157461
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung cancer patients treated with Corynebacterium parvum. Phase I toxicity study.
    Yadeau R; Bates HA; Fortuny I
    Minn Med; 1979 Sep; 62(9):673-5. PubMed ID: 503003
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Corynebacterium parvum vaccine in conjunction with immunosuppression in renal transplant in dogs.
    Munda R; Alexander JW; Stinnett JD; Weiss MA; Morris MJ
    Transplantation; 1982 Mar; 33(3):333-5. PubMed ID: 7039044
    [No Abstract]   [Full Text] [Related]  

  • 16. Inefficacy of sc Corynebacterium parvum in stage I malignant melanoma: preliminary results of a single-institution pilot study.
    Murray JL; Ishmael DR; Bottomley RH; Grozea PN; Lee ET
    Cancer Treat Rep; 1983 Feb; 67(2):191-2. PubMed ID: 6825130
    [No Abstract]   [Full Text] [Related]  

  • 17. Corynebacterium parvum-induced resistance to a methylcholanthrene fibrosarcoma.
    Gupta JD; Morahan PS; Kaplan AM
    J Reticuloendothel Soc; 1978 Jan; 23(1):1-9. PubMed ID: 627989
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy and corynebacterium parvum for induction and maintenance of remission in acute myelogenous leukaemia--a controlled study.
    Shetty PA; Pai VR; Jani PH; Antia PK; Shahane AD
    Indian J Cancer; 1983; 20(2):119-23. PubMed ID: 6580265
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of Corynebacterium parvum in pleurodesis].
    Helin T; Haahtela T
    Duodecim; 1988; 104(4):262-5. PubMed ID: 3168834
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma.
    Karakousis CP; Didolkar MS; Han T
    Cancer Treat Rep; 1981; 65(9-10):925-6. PubMed ID: 7273032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.